Colin Carpenter '09

Colin M. Carpenter develops and commercializes solutions at the interface of engineering and medicine, focusing on clinical needs in cancer diagnosis and therapy.

Since co-founding Siris Medical in 2013, Dr. Carpenter has served as its CEO, commercially introducing the first end-to-end oncology decisioning platform using artificial intelligence. Siris's award winning technology helps payers, providers, and patients determine the best treatment by learning from past success. This technology has won numerous awards, including the Rosenman Innovator award from the University of California – San Francisco, and the Best in Category award from the European Society of Radiation Oncology, and is available to millions of patients across the United States.

Prior to Siris, Dr. Carpenter trained in the Department of Radiation Oncology at Stanford, where he founded a company to commercialize a product line for GI cancer, sold by Varian Medical Systems (VMS), a Siemens Healthineers company. At Dartmouth, Dr. Carpenter led the early clinical validation of a breast cancer imaging device in collaboration with Philips to reduce false positive results. This work resulted in a US Patent, a DoD Breast Cancer Fellowship grant, and numerous publications.

Dr. Carpenter is a contributor to over 100 technical and medical publications and is an alumnus of Stanford Biodesign. He received a PhD in Engineering from Dartmouth and frequently lectures on commercialization and machine learning in medicine at Dartmouth.